BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28607017)

  • 1. High Accumulation and
    Wein S; Taudon N; Maynadier M; Tran Van Ba C; Margout D; Bordat Y; Fraisse L; Wengelnik K; Cerdan R; Bressolle-Gomeni F; Vial HJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate.
    Wein S; Maynadier M; Bordat Y; Perez J; Maheshwari S; Bette-Bobillo P; Tran Van Ba C; Penarete-Vargas D; Fraisse L; Cerdan R; Vial H
    Br J Pharmacol; 2012 Aug; 166(8):2263-76. PubMed ID: 22471905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into the mechanism of accumulation and intraerythrocytic compartmentation of albitiazolium, a new type of antimalarial.
    Wein S; Tran Van Ba C; Maynadier M; Bordat Y; Perez J; Peyrottes S; Fraisse L; Vial HJ
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5519-27. PubMed ID: 25001307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.
    Nicolas O; Margout D; Taudon N; Wein S; Calas M; Vial HJ; Bressolle FM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3631-9. PubMed ID: 16127032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
    Penarete-Vargas DM; Boisson A; Urbach S; Chantelauze H; Peyrottes S; Fraisse L; Vial HJ
    PLoS One; 2014; 9(12):e113918. PubMed ID: 25470252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
    Richier E; Biagini GA; Wein S; Boudou F; Bray PG; Ward SA; Precigout E; Calas M; Dubremetz JF; Vial HJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3381-8. PubMed ID: 17005821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs of bisthiazolium salts are orally potent antimalarials.
    Vial HJ; Wein S; Farenc C; Kocken C; Nicolas O; Ancelin ML; Bressolle F; Thomas A; Calas M
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15458-63. PubMed ID: 15492221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.
    Patel K; Batty KT; Moore BR; Gibbons PL; Bulitta JB; Kirkpatrick CM
    Antimicrob Agents Chemother; 2013 Jan; 57(1):508-16. PubMed ID: 23147722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.
    Caldarelli SA; Boisbrun M; Alarcon K; Hamzé A; Ouattara M; Salom-Roig X; Maynadier M; Wein S; Peyrottes S; Pellet A; Calas M; Vial H
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3953-6. PubMed ID: 20605450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.
    Chang ZW; Malleret B; Russell B; Rénia L; Claser C
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6859-6866. PubMed ID: 27600050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new chemical class of antimalarials.
    Brunner R; Aissaoui H; Boss C; Bozdech Z; Brun R; Corminboeuf O; Delahaye S; Fischli C; Heidmann B; Kaiser M; Kamber J; Meyer S; Papastogiannidis P; Siegrist R; Voss T; Welford R; Wittlin S; Binkert C
    J Infect Dis; 2012 Sep; 206(5):735-43. PubMed ID: 22732921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium.
    Moles E; Fernàndez-Busquets X
    Future Med Chem; 2015; 7(7):837-40. PubMed ID: 26061102
    [No Abstract]   [Full Text] [Related]  

  • 14. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers.
    Jain SA; Basu H; Prabhu PS; Soni U; Joshi MD; Mathur D; Patravale VB; Pathak S; Sharma S
    Biomaterials; 2014 Aug; 35(24):6636-45. PubMed ID: 24818881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic biochemical investigations as rationale for the design of original antimalarial drugs. An example of phospholipid metabolism.
    Vial HJ; Angelin ML; Elabbadi N; Calas M; Cordinas G; Giral L
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():251-61. PubMed ID: 1343697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective accumulation of a novel antimalarial rhodacyanine derivative, SSJ-127, in an organelle of Plasmodium berghei.
    Ikegami-Kawai M; Arai C; Ogawa Y; Yanoshita R; Ihara M
    Bioorg Med Chem; 2010 Nov; 18(22):7804-8. PubMed ID: 20970347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel.
    Sinou V; Grellier P; Schrevel J
    Antimicrob Agents Chemother; 1996 Feb; 40(2):358-61. PubMed ID: 8834880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds.
    Gumila C; Ancelin ML; Delort AM; Jeminet G; Vial HJ
    Antimicrob Agents Chemother; 1997 Mar; 41(3):523-9. PubMed ID: 9055986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development.
    McCarthy JS; Marquart L; Sekuloski S; Trenholme K; Elliott S; Griffin P; Rockett R; O'Rourke P; Sloots T; Angulo-Barturen I; Ferrer S; Jiménez-Díaz MB; Martínez MS; Hooft van Huijsduijnen R; Duparc S; Leroy D; Wells TN; Baker M; Möhrle JJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3669-75. PubMed ID: 27044554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.